James M Mock Moderna, Inc. (MRNA) insider trading activity

James M Mock is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 15,623 shares of MRNA, which is worth approximately $386,200. The most recent transaction as insider was on Apr 05, 2024, when has been sold 1,453 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.6K

33.09% 3M change

209.49% 12M change

Total Value Held $386,200

James M Mock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 05 2024	BUY Exercise of conversion of derivative security	-	1,453 Added 20.16%	5,753 Common Stock
Feb 29 2024	SELL Open market or private sale	$61,186 $94.57 p/Share	647 Reduced 13.08%	4,300 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	1,315 Added 21.0%	4,947 Common Stock
Jan 08 2024	SELL Open market or private sale	$84,727 $109.75 p/Share	772 Reduced 17.53%	3,632 Common Stock
Jan 05 2024	BUY Exercise of conversion of derivative security	-	1,452 Added 24.8%	4,404 Common Stock
Oct 06 2023	SELL Open market or private sale	$292,945 $102.5 p/Share	2,858 Reduced 49.19%	2,952 Common Stock
Oct 05 2023	BUY Exercise of conversion of derivative security	-	5,810 Added 50.0%	5,810 Common Stock

Also insider at

PKI

PERKINELMER INC Healthcare

Officer

JMM

James M Mock

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account